Efficacy of Pycnogenol® supplementation in remission phases of Sjögren syndrome.
Minerva Cardioangiol
; 66(5): 543-546, 2018 Oct.
Article
em En
| MEDLINE
| ID: mdl-30328688
ABSTRACT
BACKGROUND:
The aim of this study was to evaluate the effects of Pycnogenol® supplementation in otherwise healthy subjects with Sjögren syndrome (SS) in a remission phase, who experienced persisting symptoms impairing their quality of life.METHODS:
The control group receiving only standard treatment was composed of 14 subjects, the supplement group included 16 subjects who used Pycnogenol® supplementation.RESULTS:
ESR and oxidative stress levels were high in all subjects at inclusion; both decreased significantly with supplementation (P<0.05). Pycnogenol® significantly improved the majority of symptoms (dry eyes and mouth dryness), diminishing the need for corticosteroids and other treatments.CONCLUSIONS:
Pycnogenol® supplementation in patients with SS in a remission phase may be effective to control inflammation and reduce symptoms.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Flavonoides
/
Extratos Vegetais
/
Síndrome de Sjogren
/
Estresse Oxidativo
/
Antioxidantes
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Idioma:
En
Revista:
Minerva Cardioangiol
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
Itália